HLscience Balance Sheet Health
Financial Health criteria checks 3/6
HLscience has a total shareholder equity of ₩99.6B and total debt of ₩450.0M, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are ₩102.9B and ₩3.2B respectively.
Key information
0.5%
Debt to equity ratio
₩450.00m
Debt
| Interest coverage ratio | n/a |
| Cash | ₩27.62b |
| Equity | ₩99.62b |
| Total liabilities | ₩3.24b |
| Total assets | ₩102.86b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A239610's short term assets (₩37.0B) exceed its short term liabilities (₩2.5B).
Long Term Liabilities: A239610's short term assets (₩37.0B) exceed its long term liabilities (₩700.0M).
Debt to Equity History and Analysis
Debt Level: A239610 has more cash than its total debt.
Reducing Debt: A239610's debt to equity ratio has increased from 0.05% to 0.5% over the past 5 years.
Debt Coverage: A239610's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A239610's interest payments on its debt are well covered by EBIT.